Transoral robotic surgery for oropharyngeal cancer in the era of chemoradiation therapy

Over time, the primary treatment modality of oropharyngeal squamous cell cancers (OPSCC) is intensity-modulated radiation therapy (IMRT), eventually associated with chemotherapy (CHT). This treatment modality is preferred for reduced impact on the quality of life rather than aggressive open surgical approaches. The advent of TransOral Robotic Surgery (TORS) has rediscovered the role of surgery in the treatment of OPSCC. Although the primary chemoradiation therapy (CRT) and transoral robotic surgery (TORS) are competing for similar oncologic results, CRT may result in significant functional complaints such as severe dysphagia and feeding tube dependence and, on the other hand, TORS might result in surgical defects depending on the size of the resection and anatomic location.

Source: Auris, Nasus, Larynx - January 28, 2022 Category: ENT & OMF Authors: Giuseppe Meccariello, Giovanni Cammaroto, Giannicola Iannella, Andrea De Vito, Andrea Ciorba, Chiara Bianchini, Virginia Corazzi, Stefano Pelucchi, Claudio Vicini, Pasquale Capaccio Source Type: research